On september 23, 2022, the reporter (the son) of the lay user/patient contacted lifescan (lfs) usa, alleging that his mother¿s onetouch ultra 2 meter was reading inaccurately high compared to a calibrated lab method.This complaint was classified based on information obtained from the customer care agent (cca) during the initial call.The reporter alleged that the product issue began on (b)(6) 2022 at 4 pm.The reporter claimed that the patient obtained a blood glucose reading of ¿185 mg/dl¿ on the subject meter.The patient manages her diabetes with novolog insulin (self-adjusting dose) and the reporter informed the cca that his mother increased her insulin intake by 9 units in response to the high reading.The reporter stated at 7 pm that same day, the patient ¿had trouble breathing and passed out¿.Her son called an ambulance to take the patient to the emergency room (er).At 7:45 pm, before treatment, the patient¿s blood glucose was tested and a reading of ¿61 mg/dl¿ on an unspecified lab device was obtained.The patient was treated by an hcp with iv glucose in the emergency room (er).During troubleshooting, the cca confirmed that the patient had used an approved sample site to obtain the blood samples.The cca educated the reporter on the use of control solution.Replacement products were sent to the patient.This complaint is being reported because the patient reportedly developed symptoms suggestive of a serious injury adverse event after taking an increased dose of insulin based on alleged inaccurate high results obtained with the subject meter.
|